GL1X · GenesisL1 explorer

MolNFT v2 · #38477 · protein

Structure-Based Drug Design and Structural Biology Study of Novel Nonpeptide Inhibitors of SARS-CoV Main Protease

MolNFT v2 record #38477 on GenesisL1: PDB 2GZ8, “Structure-Based Drug Design and Structural Biology Study of Novel Nonpeptide Inhibitors of SARS-CoV Main Protease”. Protein, 306 residues. 3D structure, sequence proof, BLAST and…

PDB
2GZ8
Type
protein
Length
306 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.